Literature DB >> 57447

Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.

J Reeve, R Hesp, D Williams, P Hulme, L Klenerman, J M Zanelli, A J Darby, G W Tregear, J A Parsons.   

Abstract

Parathyroid hormone, injected daily in low dosage, exerted anabolic effects on the human skeleton, just as it does in the rat. Four postmenopausal women with primary osteoporosis were treated for six months with a synthetic fragment of human parathyroid hormone (hP.T.H. 1-34), given as a daily injection of 100 mug. This treatment caused a remarkable acceleration of bone turnover, indicated both by isotopic tracer and histological methods. At this normocalcaemic dose level, the increases in bone formation outweighed increases in resorption. Three of the four patients showed more positive calcium balances, and mean increases in calcium and phosphorus balances were statistically significant for the group as a whole, the changes being principally due to increased intestinal absorption of both elements. Many modifications of the present method of hormone administration are possible which could further increase the preponderance of anabolic effects. These results suggest that low doses of hP.T.H. 1-34, alone or in combination with other agents, may prove useful in the treatment of osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57447     DOI: 10.1016/s0140-6736(76)92216-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.

Authors:  R L Jilka; R S Weinstein; T Bellido; P Roberson; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Recombinant human parathyroid hormone.

Authors:  Jonathan Reeve
Journal:  BMJ       Date:  2002-02-23

3.  Bone disease in the elderly.

Authors:  R Smith
Journal:  Proc R Soc Med       Date:  1976-12

4.  The management of osteoporosis.

Authors:  A N Exton-Smith
Journal:  Proc R Soc Med       Date:  1976-12

Review 5.  Parathyroid hormone analogues in the treatment of osteoporosis.

Authors:  Marius E Kraenzlin; Christian Meier
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

6.  Variation in the PTH2R gene is associated with age-related degenerative changes in the lumbar spine.

Authors:  Kristina Åkesson; Max Tenne; Paul Gerdhem; Holger Luthman; Fiona E McGuigan
Journal:  J Bone Miner Metab       Date:  2013-12-31       Impact factor: 2.626

7.  In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation.

Authors:  Masako Shimada; Peter A Greer; Andrew P McMahon; Mary L Bouxsein; Ernestina Schipani
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

8.  Editorial: Estrogens and osteoporosis.

Authors:  R P Heaney
Journal:  West J Med       Date:  1976-08

Review 9.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

10.  Stimulation of creatine kinase activity in rat skeletal tissue in vivo and in vitro by protease-resistant variants of parathyroid hormone fragments.

Authors:  D Sömjen; V Vargas; A Waisman; E Wingender; W Tegge; A M Kaye
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.